These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 28122792)
1. With regard to the papers by Kumar et al. and de Leeuw and de Boer addressing the cardiovascular safety and efficacy of anti-diabetic drugs. Turner JR; Caveney E; Gillespie BS; Karnad DR; Kothari S; Metz A; Keller LH Eur Heart J Cardiovasc Pharmacother; 2017 Apr; 3(2):75-76. PubMed ID: 28122792 [No Abstract] [Full Text] [Related]
3. Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes. Xu J; Rajaratnam R Cardiovasc Diabetol; 2017 Feb; 16(1):18. PubMed ID: 28148253 [TBL] [Abstract][Full Text] [Related]
4. [Cardiovascular safety of non-insulin anti-diabetic drugs. Scientific position statement of SEMERGEN]. Prieto MÁ; Comas Samper JM; Escobar Cervantes C; Gasull Molinera V Semergen; 2014; 40(5):261-73. PubMed ID: 24882393 [TBL] [Abstract][Full Text] [Related]
5. Meta-analysis Addressing the Cardiovascular Safety of Bexagliflozin in Patients With Type 2 Diabetes Mellitus. Patoulias D; Dimosiari A Am J Cardiol; 2022 Sep; 178():178-179. PubMed ID: 35773042 [No Abstract] [Full Text] [Related]
6. [Cardiovascular safety of new type 2 diabetes drugs]. Hormigo Pozo A; Mancera Romero J Semergen; 2014 Mar; 40(2):55-6. PubMed ID: 24655909 [No Abstract] [Full Text] [Related]
7. Drugs for type 2 diabetes mellitus: the imperative for cardiovascular outcome assessment. Gore MO; McGuire DK Diab Vasc Dis Res; 2012 Apr; 9(2):85-8. PubMed ID: 22496441 [No Abstract] [Full Text] [Related]
8. Letter by Wang et al Regarding Article, "Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks". Wang D; Chen T; Yang X Circulation; 2019 Oct; 140(16):e720-e721. PubMed ID: 31609657 [No Abstract] [Full Text] [Related]
9. Newer glucose-lowering drugs and risk of dementia: A meta-analysis of cardiovascular outcome trials. Tang H; Niu S; Brown J; Wei J; Shao H; Bian J; Guo J J Am Geriatr Soc; 2022 Sep; 70(9):2719-2722. PubMed ID: 35612586 [No Abstract] [Full Text] [Related]
10. [The influence of drugs used in the treatment of diabetes type 2 on the cardio-vascular risk]. Kern A; Zaleska M; Możeńska O; Bil J Wiad Lek; 2017; 70(4):827-833. PubMed ID: 29064812 [TBL] [Abstract][Full Text] [Related]